GeoVax Labs, Inc.
NASDAQ: GOVX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David Alan Dodd
- Employees
- 17
- Headquarters
- Smyrna, United States
- IPO year
- 2020
- Market cap
- $1.3M
- Website
- https://www.geovax.com
Loading GOVX…
Loading profile data…Frequently asked questions about GOVX
What does GeoVax Labs, Inc. (GOVX) do?
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes s...
Where does GOVX trade?
GeoVax Labs, Inc. (GOVX) trades on the NASDAQ Capital Market.
What sector is GOVX in?
GeoVax Labs, Inc. (GOVX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of GeoVax Labs, Inc.?
David Alan Dodd is the chief executive officer of GeoVax Labs, Inc. (GOVX).
Where is GeoVax Labs, Inc. headquartered?
GeoVax Labs, Inc. is headquartered in United States.
Does GOVX pay a dividend?
GeoVax Labs, Inc. (GOVX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GOVX go public?
GeoVax Labs, Inc. (GOVX) completed its initial public offering in 2020.